U.S., July 21 -- ClinicalTrials.gov registry received information related to the study (NCT07715149) titled 'A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function' on July 13.
Brief Summary: This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.
Study Start Date: July 14
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Hepatic Impairment (HI)
Intervention:
DRUG: D-2570
D-2570 tablet, administered orally as a single dose
Recruitment Status: RECRUITING
Sponsor: InventisBio Co., Ltd
Published by HT Di...